How Does the Anti Viral Tablet Worth Rs 35 Help COVID-19 Patients? Doctors InformHealthcareBy Roshini Muthukumar05 Aug 2020 13:39 ISTAn affordable drug, Favipiravir is the only oral antiviral approved in India for coronavirus treatment.Read More
10 Critical Things You Need to Know About Itolizumab, Biocon's New COVID-19 DrugHealthcareBy Roshini Muthukumar13 Jul 2020 16:34 ISTBiocon Limited, has received the Drug Controller General of India’s (DCGI) approval to market ‘Itolizumab,’ a drug previously used to treat chronic plaque psoriasis, for restricted emergency use on COVID-19 patients.Read More
/english-betterindia/media/post_attachments/uploads/2020/08/Featured-6.jpg)
/english-betterindia/media/post_attachments/uploads/2020/07/Biocon.jpg)